Jefferies maintains a Buy rating and $25 price target on Bruker (NASDAQ: BRKR) following the surprise departure of CFO, Charlie ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Management Changes

William Blair Downgrades Bruker (BRKR) to Market PerformMay 21, 2015 6:43 AM Mizuho Securities Downgrades Bruker (BRKR) to NeutralMay 21, 2015 6:43 AM After-Hours Stock Movers 05/20: (EGHT) (CRM) (WSM) Higher; (XNET) (NTAP) (BRKR) Lower (more...)May 20, 2015 5:44 PM Bruker (BRKR) CFO Wagner to ResignMay 20, 2015 4:10 PM Management Change: Chief Financial Officer of Ortho Clinical DiagnosticsMay 20, 2015 4:06 PM Bruker Announces Resignation of Chief Financial Officer and Appointment of Interim Chief Financial OfficerMay 20, 2015 4:04 PM